Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.

Alduaij, Waleed; Ivanov, Andrei; Honeychurch, Jamie; Cheadle, Eleanor J; Potluri, Sandeep; Lim, Sean H; Shimada, Kazuyuki; Chan, Claude H T; Tutt, Alison; Beers, Stephen A; Glennie, Martin J; Cragg, Mark S; Illidge, Tim M

Alduaij, Waleed; Ivanov, Andrei; Honeychurch, Jamie; Cheadle, Eleanor J; Potluri, Sandeep; Lim, Sean H; Shimada, Kazuyuki; Chan, Claude H T; Tutt, Alison; Beers, Stephen A; Glennie, Martin J; Cragg, Mark S; Illidge, Tim M.

Affiliation

Alduaij W; Targeted Therapy Group, Paterson Institute for Cancer Research, School of Cancer and Enabling Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, UK.

Blood ; 117(17): 4519-29, 2011 Apr 28.

Article in En | MEDLINE | ID: mdl-21378274

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Cell Death / Antibodies, Monoclonal / Antineoplastic Agents Limits: Humans Language: En Journal: Blood Year: 2011 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google